Gynecologic clear cell cancers are aggressive malignant neoplasms with low response rates to chemotherapy. Among patients with advanced clear cell ovarian and endometrial cancers who received ...

CHICAGO -- Clinical activity and survival outcomes improved with the addition of ipilimumab (Yervoy) to nivolumab (Opdivo) in patients with ovarian or other gynecologic clear cell carcinomas, ...

XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...

Highly anticipated overall survival results from the KEYNOTE-564 trial support the use of adjuvant pembrolizumab as a standard of care after nephrectomy for patients with clear cell RCC at increased ...

Clear cell endometrial cancer (endometrial CCC) is a rare type of womb cancer that can grow quickly. It typically affects people who have been through menopause. There are several types of womb cancer ...

Adjuvant everolimus does not improve recurrence-free or overall survival in patients with papillary and chromophobe subtypes of non–clear cell renal cell carcinoma (RCC) and is associated with higher ...